LDS/Medical Tests/Brucella Antibody, IgG and IgM

Brucella Antibody, IgG and IgM

Brucellosis is a febrile zoonotic disease caused by slowly growing gram-negative intracellular coccobacilli of the Brucella species such as Brucella abortus, Brucella melitensis, and Brucella suis.

Brucellosis is a worldwide re-emerging zoonosis and the most frequent laboratory-acquired bacterial infection, causing severe disease in humans with nonspecific clinical signs affecting numerous organs. Contact with infected animals, ingestion of contaminated animal products, and handling of Brucella isolates in laboratories are risk factors. Additional risk groups include slaughterhouse employees, veterinarians, and hunters who come in contact with infected animals and contract the disease through unprotected wounds. In humans, brucellosis can cause a range of symptoms that are similar to the flu and may include fever, headaches, back pain, and physical weakness. Additionally, severe complications of the central nervous system or other organs may occur. Brucellosis can also cause long-lasting or chronic symptoms that include recurrent fevers, joint pain, and fatigue.

The standard tube agglutination test (SAT) is the most widely used serologic test for the confirmation of human brucellosis. In many laboratories, this test has been adapted to run in microtiter plates. The detection of seroconversion or high antibody titers ( ≥ 1/160) are considered diagnostic, together with a compatible clinical presentation. The lack of seropositivity in patients with strongly suspected clinical picture may be attributed to the performance of tests early in the course of infection, the presence of blocking antibodies (non-agglutinating, incomplete) or the so-called "prezone" phenomenon. Enzyme immunoassays (ELISA), which measure specific IgM, IgG, and IgA antibodies, allow for a better interpretation of the clinical situation and overcome the false negatives/positives that may arise in SAT.

Although the definitive diagnosis of brucellosis requires isolation of the bacterium from blood, bone marrow, or tissue samples, blood culturing of Brucella is time-consuming and unreliable. Molecular techniques like the polymerase chain reaction and restriction fragment length polymorphism are needed to differentiate species and strains within the genus Brucella.

  • In diagnosis of brucellosis infection
  • Monitoring the treatment

Increased in:

  • Brucella infection
  • Also increased in recent brucellergin skin test
  • Might be false positive in infections with Francisella tularensis, Yersinia enterocolitica, salmonella, Rocky Mountain spotted fever; vaccinations for cholera and tularemia.
  • No seroconversion or ELISA positivity is present in Brucella canis infection

 Negative (Non-reactive)
 

 

Bacterial Agglutination, ELISA.

Serum (SST).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Brucella culture, Brucellosis by PCR, Demonstration of Brucella species in a clinical specimen by immunofluorescence.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login